DXS International plc (AQSE: DXSP): Statement for the 2025 Annual General Meeting

Summary by AI BETAClose X

DXS International plc anticipates broadly flat trading for the half year ending 31 October 2025, with a marginal loss expected, and projects calendar year 2026 to be operationally positive due to likely NHS funding renewal between April and June. The company has rebuilt its SMART Referral solution and is completing a Cholesterol Prototype, while continuing cost management with further senior management cuts anticipated. Separately, a cyber security incident was announced this morning.

Disclaimer*

UK 100

Latest directors dealings